Potassium Allyltrifluoroborate - CAS 233664-53-4
Catalog: |
BB018021 |
Product Name: |
Potassium Allyltrifluoroborate |
CAS: |
233664-53-4 |
Synonyms: |
potassium;trifluoro(prop-2-enyl)boranuide; potassium;trifluoro(prop-2-enyl)boranuide |
IUPAC Name: | potassium;trifluoro(prop-2-enyl)boranuide |
Description: | Organotrifluoroborate involved in: Catalytic allylboration; Stereoselective nucleophilic addition; Pd-catalyzed heterocyclizations; Oxidation reactions and Oxidative Mannich reactions; Cross-coupling reactionsOrganotrifluoroborates as versatile and stable boronic acid surrogates. |
Molecular Weight: | 147.98 |
Molecular Formula: | C3H5F3BK |
Canonical SMILES: | [B-](CC=C)(F)(F)F.[K+] |
InChI: | InChI=1S/C3H5BF3.K/c1-2-3-4(5,6)7;/h2H,1,3H2;/q-1;+1 |
InChI Key: | TVPZAMJXLCDMIT-UHFFFAOYSA-N |
Melting Point: | >300 °C |
Flash Point: | Not applicable |
Purity: | 95 % |
MDL: | MFCD07368222 |
LogP: | 2.01980 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021127743-A1 | Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof | 20191223 |
WO-2021086833-A1 | Small molecule inhibitors of kras g12c mutant | 20191028 |
WO-2019204537-A1 | N-[4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol e-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs) | 20180420 |
CN-112074519-A | N- [ 4-oxo-2, 3-dihydro-1, 5-benzoxazepin-3-yl ] -5, 6-dihydro-4H-pyrrolo [1,2-B ] pyrazole-2-carboxamide derivatives and related compounds as RIP1 kinase inhibitors for the treatment of e.g. Irritable Bowel Syndrome (IBS) | 20180420 |
EP-3781571-A1 | N-[4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazol e-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs) | 20180420 |
Complexity: | 69.4 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 148.0073463 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 148.0073463 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 0 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Boronic Acids and Esters
-
[2454490-85-6]
2-(7,8-Difluoro-1-naphthyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
-
[766549-26-2]
2-Chloro-4-hydroxyphenylboronic Acid
-
[1257724-90-5]
2-(3-Hydroxyphenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione
-
[1171897-39-4]
5-(Boc-amino)pyridine-3-boronic Acid Pinacol Ester
-
[2005430-90-8]
3-[[2-(Trimethylsilyl)ethoxy]methyl]-3H-imidazo[4,5-b]pyridine-6-boronic Acid Pinacol Ester
-
[2247367-07-1]
4,4,4',4',5,5,5',5'-octaethyl-2,2'-bi(1,3,2-dioxaborolane)
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS